Britt Vitalone - McKesson Chief Financial Officer, Executive Vice President
MCK Stock | USD 562.78 7.29 1.28% |
President
Mr. Britt Vitalone was appointed Chief Financial Officer, Executive Vice President of the Company effective January 1, 2018. He is currently Senior Vice President and Chief Financial Officer of U.S. Pharmaceutical and McKesson Specialty Health, which includes responsibility for all daytoday financial and accounting operations including long range planning and financial oversight of new strategic initiatives. From 2012 to 2014, Mr. Vitalone served as the Companys Senior Vice President, Corporationrationrate Financial Planning and Analysis and Mergers Acquisitions Finance with responsibility for the Companys financial planning, cash flow forecasting, mergers an acquisitions and competitive analysis functions. From 2009 to 2012, he was Senior Vice President and Chief Financial Officer of the Companys MedicalSurgical business, having joined the Company in 2006 as Vice President, Finance of the same business. Prior to joining the Company, Mr. Vitalone held a variety of financial leadership positions with General Electric Financial Assurance, CarMax, Inc. and Bausch Lomb Inc since 2018.
Age | 54 |
Tenure | 6 years |
Address | 6555 State Highway 161, Irving, TX, United States, 75039 |
Phone | 972 446 4800 |
Web | https://www.mckesson.com |
Britt Vitalone Latest Insider Activity
Tracking and analyzing the buying and selling activities of Britt Vitalone against McKesson stock is an integral part of due diligence when investing in McKesson. Britt Vitalone insider activity provides valuable insight into whether McKesson is net buyers or sellers over its current business cycle. Note, McKesson insiders must abide by specific rules, including filing SEC forms every time they buy or sell McKesson'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Britt Vitalone over two weeks ago Disposition of 1475 shares by Britt Vitalone of McKesson subject to Rule 16b-3 | ||
Britt Vitalone over three months ago Disposition of 6 shares by Britt Vitalone of McKesson at 560.73 subject to Rule 16b-3 | ||
Britt Vitalone over a year ago Sale by Britt Vitalone of 13330 shares of McKesson |
McKesson Management Efficiency
The company has Return on Asset of 0.0392 % which means that on every $100 spent on assets, it made $0.0392 of profit. This is way below average. McKesson's management efficiency ratios could be used to measure how well McKesson manages its routine affairs as well as how well it operates its assets and liabilities. Return On Capital Employed is expected to rise to 0.27 this year, although the value of Return On Tangible Assets will most likely fall to 0.04. At this time, McKesson's Total Current Liabilities is quite stable compared to the past year. Non Current Liabilities Total is expected to rise to about 17.5 B this year, although the value of Liabilities And Stockholders Equity will most likely fall to about 36.5 B.Similar Executives
Showing other executives | PRESIDENT Age | ||
Christopher Lowery | Owens Minor | 57 | |
David Wilson | Cardinal Health | N/A | |
Brian Rice | Cardinal Health | 57 | |
Jonathan Leon | Owens Minor | 57 | |
George Henriques | Patterson Companies | 64 | |
Paul Guggenheim | Patterson Companies | 64 | |
Les Korsh | Patterson Companies | 54 | |
Timothy Rogan | Patterson Companies | 52 | |
Michael Lowry | Owens Minor | 62 | |
James CPA | Henry Schein | 70 | |
John Wright | Patterson Companies | N/A | |
Jorge Sahlieh | Cardinal Health | N/A | |
Michael Pintek | Cardinal Health | 55 | |
Patricia English | Cardinal Health | 44 | |
Shana Neal | Owens Minor | 55 | |
Michael Ettinger | Henry Schein | 63 | |
Andrew Long | Owens Minor | 59 | |
Mark Zacur | Owens Minor | 57 | |
Kevin Pohlman | Patterson Companies | 61 | |
Patricia CPA | Cardinal Health | 44 | |
Frederic Pech | EDAP TMS SA | 55 |
Management Performance
Return On Asset | 0.0392 |
McKesson Leadership Team
Elected by the shareholders, the McKesson's board of directors comprises two types of representatives: McKesson inside directors who are chosen from within the company, and outside directors, selected externally and held independent of McKesson. The board's role is to monitor McKesson's management team and ensure that shareholders' interests are well served. McKesson's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, McKesson's outside directors are responsible for providing unbiased perspectives on the board's policies.
Lori Schechter, Executive Vice President Chief Compliance Officer, General Counsel | ||
Holly Weiss, VP Relations | ||
Pete Slone, Senior Affairs | ||
W Dunbar, Independent Director | ||
Bradley Lerman, Independent Director | ||
LeAnn Smith, Executive Officer | ||
Kenneth Washington, Independent Director | ||
M Jacobs, Independent Director | ||
Kirk Kaminsky, President Business | ||
Edward Mueller, Independent Chairman of the Board | ||
Nancy Avila, Chief VP | ||
James Hinton, Director | ||
Richard Carmona, Independent Director | ||
Marie Knowles, Independent Director | ||
N Coles, Independent Director | ||
Linda Mantia, Independent Director | ||
Nancy Flores, Executive Vice President, Chief Technology Officer, Chief Information Officer | ||
Tracy Faber, Chief Human Resource Officer, Executive Vice President | ||
Susan Salka, Independent Director | ||
Kevin Emerson, Interim Senior Vice President Chief Accounting Officer, Controller | ||
Tom Rodgers, Executive Vice President and Chief Strategy and Business Development Officer | ||
Paul Smith, Senior Taxes | ||
Donald Knauss, Independent Director | ||
Maria Martinez, Independent Director | ||
Michele JD, Executive Officer | ||
Brad Lerman, Independent Director | ||
Kathleen Thompson, Director | ||
Rachel Rodriguez, Vice Relations | ||
Michele Lau, Executive Officer | ||
Britt Vitalone, Chief Financial Officer, Executive Vice President | ||
Thomas MBA, Executive Officer | ||
Britt CPA, Executive CFO | ||
Napoleon Rutledge, Senior Vice President Chief Accounting Officer, Controller | ||
Francisco Fraga, Chief VP | ||
Brian Tyler, President, Chief Executive Officer, Chief Operating Officer, Director | ||
MChristine Jacobs, Independent Director | ||
Lori JD, Board Advisor | ||
Dominic Caruso, Independent Director |
McKesson Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is McKesson a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Asset | 0.0392 | ||||
Profit Margin | 0.01 % | ||||
Operating Margin | 0.01 % | ||||
Current Valuation | 77.07 B | ||||
Shares Outstanding | 126.94 M | ||||
Shares Owned By Insiders | 0.09 % | ||||
Shares Owned By Institutions | 89.08 % | ||||
Number Of Shares Shorted | 1.91 M | ||||
Price To Earning | 26.98 X | ||||
Price To Book | 5.04 X |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in McKesson. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. For more information on how to buy McKesson Stock please use our How to buy in McKesson Stock guide.You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of McKesson. If investors know McKesson will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about McKesson listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.62) | Dividend Share 2.57 | Earnings Share 19.1 | Revenue Per Share 2.5 K | Quarterly Revenue Growth 0.213 |
The market value of McKesson is measured differently than its book value, which is the value of McKesson that is recorded on the company's balance sheet. Investors also form their own opinion of McKesson's value that differs from its market value or its book value, called intrinsic value, which is McKesson's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because McKesson's market value can be influenced by many factors that don't directly affect McKesson's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between McKesson's value and its price as these two are different measures arrived at by different means. Investors typically determine if McKesson is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, McKesson's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.